Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory affairs
Pharma
With strong data, Lilly plots filings for weekly insulin asset
With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.
Fraiser Kansteiner
Jun 23, 2025 10:16am
Lack of global regulatory alignment spurs bad actors, FDA says
May 9, 2024 10:15am
Pharma heads for cancer first line, causing early-stage rethink
Nov 17, 2023 3:00am
Regulatory tracker: Bayer adds new Kerendia CV outcomes nod
Aug 29, 2022 9:48am
